Switch-like phosphorylation of WRN integrates end-resection with RAD51 metabolism at collapsed replication forks
Nucleic Acids Research · 11.11.2024 · 52 (20) · 12334-12350
DOI: 10.1093/nar/gkae807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 24.09.2024. Verfasst von Valentina Palermo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environment and Health, Mechanisms, Biomarkers and Models Section, Genome Stability Group, Istituto Superiore di Sanità, Viale Regina E…. Hauptthemen laut MEDLINE: Rad51 Recombinase, Werner Syndrome Helicase, DNA Replication, DNA Breaks, Double-Stranded. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Fondazione Telethon.
Abstract (Originalsprache)
Replication-dependent DNA double-strand breaks are harmful lesions preferentially repaired by homologous recombination (HR), a process that requires processing of DNA ends to allow RAD51-mediated strand invasion. End resection and subsequent repair are two intertwined processes, but the mechanism underlying their execution is still poorly appreciated. The WRN helicase is one of the crucial factors for end resection and is instrumental in selecting the proper repair pathway. Here, we reveal that ordered phosphorylation of WRN by the CDK1, ATM and ATR kinases defines a complex regulatory layer essential for correct long-range end resection, connecting it to repair by HR. We establish that long-range end resection requires an ATM-dependent phosphorylation of WRN at Ser1058 and that phosphorylation at Ser1141, together with dephosphorylation at the CDK1 site Ser1133, is needed for the proper metabolism of RAD51 foci and RAD51-dependent repair. Collectively, our findings suggest that regulation of WRN by multiple kinases functions as a molecular switch to allow timely execution of end resection and repair at replication-dependent DNA double-strand breaks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Environment and Health, Mechanisms, Biomarkers and Models Section, Genome Stability Group, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
- FAST, Core Facilities Service, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
- Department of Biosciences, Genomic Instability and Human Pathologies Section, Università degli Studi di Milano, Via Giovanni Celoria 26, 20133 Milan, Italy.
- Istituto Nazionale di Biostrutture e Biosistemi, Viale delle Medaglie d'Oro 305, 00134 Rome, Italy.
ORCID-Profile: Achille Pellicioli, Annapaola Franchitto, Pietro Pichierri
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- Fondazione Telethon
Zitieren
APA
Palermo, V., Malacaria, E., Semproni, M., Camerini, S., Casella, M., Perdichizzi, B., Valenzisi, P., Sanchez, M., Marini, F., Pellicioli, A., Franchitto, A., & Pichierri, P. (2024). Switch-like phosphorylation of WRN integrates end-resection with RAD51 metabolism at collapsed replication forks. Nucleic Acids Research, 52(20), 12334-12350. https://doi.org/10.1093/nar/gkae807
Vancouver
Palermo V, Malacaria E, Semproni M, Camerini S, Casella M, Perdichizzi B, et al. Switch-like phosphorylation of WRN integrates end-resection with RAD51 metabolism at collapsed replication forks. Nucleic Acids Research. 2024;52(20):12334-12350. doi:10.1093/nar/gkae807
BibTeX
@article{Palermo2024,
author = {Palermo, Valentina and Malacaria, Eva and Semproni, Maurizio and Camerini, Serena and Casella, Marialuisa and Perdichizzi, Benedetta and Valenzisi, Pasquale and Sanchez, Massimo and Marini, Federica and Pellicioli, Achille and Franchitto, Annapaola and Pichierri, Pietro},
title = {Switch-like phosphorylation of WRN integrates end-resection with RAD51 metabolism at collapsed replication forks},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {20},
pages = {12334--12350},
doi = {10.1093/nar/gkae807}
}
EUVIMED